New patent expiration for Currax drug ONZETRA XSAIL
Annual Drug Patent Expirations for ONZETRA+XSAIL Onzetra Xsail is a drug marketed by Currax and is included in one NDA. […]
New patent expiration for Currax drug ONZETRA XSAIL Read Post »
Annual Drug Patent Expirations for ONZETRA+XSAIL Onzetra Xsail is a drug marketed by Currax and is included in one NDA. […]
New patent expiration for Currax drug ONZETRA XSAIL Read Post »
Annual Drug Patent Expirations for DOPTELET Doptelet is a drug marketed by Akarx Inc and is included in one NDA.
New patent expiration for Akarx Inc drug DOPTELET Read Post »
Annual Drug Patent Expirations for OZEMPIC Ozempic is a drug marketed by Novo and is included in one NDA. It
Annual Drug Patent Expirations for FERAHEME Feraheme is a drug marketed by Covis and is included in one NDA. It
Annual Drug Patent Expirations for KENGREAL Kengreal is a drug marketed by Chiesi and is included in one NDA. It
FERAHEME (ferumoxytol) Covis Patent: 6,599,498 Expiration: Jun 30, 2023 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of June 25, 2023 Read Post »
FERAHEME (ferumoxytol) Covis Patent: 6,599,498 Expiration: Jun 30, 2023 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of June 25, 2023 Read Post »
Annual Drug Patent Expirations for PEPAXTO Pepaxto is a drug marketed by Oncopeptides Ab and is included in one NDA.
New patent expiration for Oncopeptides Ab drug PEPAXTO Read Post »
Annual Drug Patent Expirations for LOSEASONIQUE Loseasonique is a drug marketed by Teva Branded Pharm and is included in one
New patent expiration for Teva Branded drug LOSEASONIQUE Read Post »
Get fresh news and insights, drug patent expirations & more…